Literature DB >> 11218209

Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib).

T Leino1, K Auranen, P H Mäkelä, H Käyhty, A K Takala.   

Abstract

Natural immunity to Haemophilus influenzae type b (Hib) is based primarily on antibodies that are thought to develop in response to subclinical infections. Wide use of conjugated Hib vaccines could lead to decreases in circulating Hib bacteria, thereby diminishing antibody levels in the unvaccinated. We applied a statistical model to estimate the duration of natural immunity to Hib under different forces of infection. Prior to the introduction of conjugated Hib vaccines, new Hib infections were estimated to occur once in 4 years and the antibody concentration to stabilize at a level around 1 microg/ml. In the absence of new stimuli, i.e. infection, 57% of the unvaccinated population would become susceptible to invasive disease (antibody levels < 0.15 microg/ml) in 10 years. Due to an interaction between the force of infection and the duration of immunity, in some situations numbers of invasive infections could increase in unvaccinated cohorts. This theoretical scenario has yet to be observed in practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11218209      PMCID: PMC2869642          DOI: 10.1017/s0950268800004799

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Authors:  Eli B Nix; Nicole Hawdon; Sean Gravelle; Birubi Biman; Malcolm Brigden; Saleem Malik; William McCready; Garry Ferroni; Marina Ulanova
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

2.  Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study.

Authors:  Jodie McVernon; Caroline L Trotter; Mary P E Slack; Mary E Ramsay
Journal:  BMJ       Date:  2004-09-18

3.  Delay in booster schedule as a control parameter in vaccination dynamics.

Authors:  Zhen Wang; Gergely Röst; Seyed M Moghadas
Journal:  J Math Biol       Date:  2019-09-07       Impact factor: 2.259

4.  Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.

Authors:  Angjelina Konini; Eli Nix; Marina Ulanova; Seyed M Moghadas
Journal:  Prev Med Rep       Date:  2016-01-26

5.  Specific antibodies against vaccine-preventable infections: a mother-infant cohort study.

Authors:  Christine Jones; Louisa Pollock; Sara M Barnett; Anna Battersby; Beate Kampmann
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

6.  Visiting sick people: is it really detrimental to our health?

Authors:  David Fouchet; John O'Brien; Dominique Pontier
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

7.  Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.

Authors:  Nadia A Charania; Seyed M Moghadas
Journal:  BMC Public Health       Date:  2017-09-13       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.